At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Standard Surgical resection +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Randomized Surgical Trial Comparing the Efficacy of LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Standard Surgical Resection in Women With Stage IIIC or Stage IVA Epithelial Ovarian Cancer
In Brief
A clinical study evaluating Standard Surgical resection and LIGASURE for Epithelial Ovarian Cancer. Completed, enrolled 50 participants across 2 sites.
Detailed Summary
The objective of this prospective randomized surgical trial is to evaluate whether the use of the LIGASURE surgical device during omentectomy and/or recto-sigmoid resection for women with ovarian cancer will reduce the surgical time compared to standard surgical resection using clamps and surgical ligatures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEpithelial Ovarian Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
First PostedMar 2012
Primary CompletionSep 2014
TodayJul 2026
First PostedMar 9, 2012
Enrollment StartJan 1, 2011
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 14.3 years ago
Interventions
Standard Surgical resectionother
standard surgical resection using clamps and surgical ligatures
LIGASUREdevice
resection using the FDA-approved LIGASURE device during omentectomy and resection of the recto-sigmoid portion of the colon